Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 3:03 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | EcoR1 Capital, LLC | 2,759,505 5.900% | 655,555 (+31.16%) | Filing History |
| 2022-02-14 2:35 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 7,731,846 16.400% | 1,916,636 (+32.96%) | Filing History |
| 2022-02-14 1:12 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | FEDERATED HERMES INC. FHI | 2,474,500 5.280% | 2,474,500 (New Position) | Filing History |
| 2022-02-10 4:21 pm Unchanged | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | ELI LILLY & Co LLY | 2,319,396 4.900% | 0 (Unchanged) | Filing History |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 3,776,524 8.052% | 352,389 (+10.29%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 3,297,480 7.000% | 1,268,223 (+62.50%) | Filing History |
| 2021-09-10 1:36 pm Purchase | 2021-08-31 | 13G | Avidity Biosciences, Inc. RNA | T. Rowe Price Associates, Inc. | 5,815,210 12.700% | 5,815,210 (New Position) | Filing History |
| 2021-02-16 3:10 pm Sale | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management LP | 2,464,547 6.570% | -49,998 (-1.99%) | Filing History |
| 2021-02-16 12:10 pm Purchase | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | EcoR1 Capital, LLC | 2,103,950 5.600% | 2,103,950 (New Position) | Filing History |
| 2021-02-12 4:43 pm Purchase | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | ELI LILLY & Co LLY | 2,319,396 6.200% | 2,319,396 (New Position) | Filing History |
| 2021-02-08 10:17 am Purchase | 2021-02-05 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 3,424,135 9.124% | 591,283 (+20.87%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | BlackRock Inc. BLK | 2,029,257 5.400% | 2,029,257 (New Position) | Filing History |
| 2020-07-10 11:38 am Purchase | 2020-07-09 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 2,832,852 7.552% | 909,887 (+47.32%) | Filing History |
| 2020-06-26 4:17 pm Purchase | 2020-06-16 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management LP | 2,514,545 6.700% | 2,514,545 (New Position) | Filing History |
| 2020-06-22 09:14 am Purchase | 2020-06-11 | 13D | Avidity Biosciences, Inc. RNA | RTW Investments, LP | 3,995,000 11.300% | 3,995,000 (New Position) | Filing History |
| 2020-06-19 10:30 am Purchase | 2020-06-19 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 1,922,965 5.439% | 1,922,965 (New Position) | Filing History |